Investor Relations
Akebia Therapeutics
Since our founding in 2007, Akebia (Nasdaq: AKBA) has been focused on achieving better outcomes for people with kidney disease. We are a leader in the renal community – a fully integrated biopharmaceutical company with capabilities ranging from research through commercialization.
We have a portfolio focused on addressing significant unmet needs for people living with kidney disease.
OUR MEDICINE
RESEARCH & DEVELOPMENT
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet
Akebia Therapeutics
180 Third Ave, Floor 2
Waltham, MA 02452
+1 617.871.2098 phone
+1 617.871.2099 fax